Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001102624-12-000256
Filing Date
2012-03-30
Accepted
2012-03-30 14:38:31
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-K bostontherapeutics10k.htm 10-K 1075573
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 17490
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 17759
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 8480
5 EXHIBIT 32.2 exh32_2.htm EX-32.2 7935
  Complete submission text file 0001102624-12-000256.txt   2456761

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bstn-20111231.xml EX-101.INS 219426
7 XBRL TAXONOMY EXTENSION SCHEMA bstn-20111231.xsd EX-101.SCH 9620
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstn-20111231_cal.xml EX-101.CAL 22931
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstn-20111231_def.xml EX-101.DEF 14709
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstn-20111231_lab.xml EX-101.LAB 86786
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstn-20111231_pre.xml EX-101.PRE 62688
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 12728266
SIC: 2834 Pharmaceutical Preparations